Liu, Chun-Yu <br/><br/>
EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  02 2017 
 - 112-123 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2016.11.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Autoantigens--genetics<br/>Disease Models, Animal<br/>ErbB Receptors--metabolism<br/>Erlotinib Hydrochloride--pharmacology<br/>Heterografts<br/>Humans<br/>Intracellular Signaling Peptides and Proteins<br/>Membrane Proteins--genetics<br/>Mice<br/>Mice, Nude<br/>RNA, Messenger--metabolism<br/>Signal Transduction--drug effects<br/>Triple Negative Breast Neoplasms--drug therapy<br/>Tumor Cells, Cultured<br/>ets-Domain Protein Elk-1--genetics